image
Healthcare - Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities KYMR - Kymera Therapeutics, Inc.

image
4.19 M
LAST VALUE
-87.06%
2 YEAR CAGR
-39.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR